Friday, January 21, 2022 8:46:44 PM
Secondly I have to tell you that you are wrong. The Share Structure CAN'T LIE, the fact that this is going from $0.0395 to $0.02 is not dilution. Is just the place where it supposed to be. Before the January 3rd. News the Stock price was trading at 0.0195- 0.021 that's the bottom of having 2.311B shares. The only issues shares was the last in November, which is on the last 10Q:
On November 4, 2021, we issued 12,500,000 shares of common stock, valued at $0.074 per share, for consulting services.
On November 12, 2021, we issued 2,500,000 shares of common stock, valued at $0.0101 per share, for consulting services.
And that makes 2.311 Billion Shares, and the other million is him converting 1M shares for salaries.January 3rd.
Now we are at 2.312B
So this guy is saying the truth, I'm not giving him the benefit of the doubt because he's the CEO, I'm just researching and being honest.
Let's see now the OS number as of Friday Jan. 21 we have $49'600,000 Market Capital divided between Stock Price $0.0216, equals the OS Number 2.312B.
The share structure still the same there's no Dilution.
There's shorters taking advantage of the " silent period" to bring the Stock Price down from where it was, because SHORTERS MAKE MONEY WHEN PRICE FALLS, so they have a lot of power to make sure the price dip.
But IMO there's too many catalyst not to expect this Stock to skyrocket. This is just temporary IMO again.
I'm showing you evidence that there's no dilution here.
Recent TSOI News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 07:15:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 07:12:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/21/2024 10:25:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/20/2024 11:16:15 AM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/08/2024 05:15:25 AM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 02/06/2024 11:34:40 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/22/2024 08:42:55 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 01/17/2024 11:15:01 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 01/04/2024 09:03:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/22/2023 07:44:34 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2023 05:39:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/16/2023 11:17:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/16/2023 11:13:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/13/2023 06:50:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/13/2023 05:44:55 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/21/2023 09:24:52 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/15/2023 11:10:01 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/07/2023 08:29:10 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM